MedPage Today on MSNOpinion
FDA expert panels raise legal, credibility questions
Handpicked panels don't fulfill federal requirements, group argues ...
6:14 p.m. July 24, 2025: An earlier version of this article said the name of the chief of maternal and fetal medicine at MetroWest Medical Center in Framingham, Mass., is Dr. David Urato. He is Dr.
The FDA approved changes to the labels for six menopausal hormone therapy products in a move the agency said clarifies risk ...
Hosted on MSN
FDA panel backs menopausal hormone therapy
An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for menopause that critics say have discouraged women for decades from using ...
An FDA panel of government physicians and scientists convened on March 10 to discuss the potential link between anesthesia and cognitive damage in children but left with more questions than answers, ...
A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...
The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic ...
The FDA has lifted longstanding and the most severe warnings off of hormone replacement therapies for menopausal women.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results